Literature DB >> 32122951

A digital media attention diversion improves mood and fear in patients receiving chemotherapy for recurrent gynecologic malignancies: results of a randomized trial.

Ryan Spencer1, Vinita Alexander2, Jens Eickhoff3, Kaitlin Woo3, Erin Costanzo4, Nick Marx5, Stephen Rose6.   

Abstract

BACKGROUND: Recurrent gynecologic cancer patients experience symptoms that affect psychologic, emotional, social, and physical well-being. Chemotherapy can further exacerbate these symptoms. Poor mood, pain, and fatigue are linked and are detrimental to quality of life. Interventions targeting these symptoms may improve patient-reported outcomes and performance status.
OBJECTIVES: To determine the ability of a humorous digital media attention diversion to improve symptom domains of positive and negative mood during chemotherapy for patients with recurrent gynecologic cancers. STUDY
DESIGN: This randomized, crossover clinical trial enrolled women with recurrent gynecologic cancers. Subjects participated over three cycles of chemotherapy. The primary outcome was the change in mood on the validated Positive and Negative Affect Scale-Extended (PANAS-X) instrument, which measures positive and negative affect domains. All subjects completed the PANAS-X after receiving chemotherapy during cycle 1 on study. In atudy arm 1, subjects watched their choice of humorous movies on a digital media device while receiving chemotherapy during cycle 2 on study. They selected from non-humorous movies during cycle 3 on study. In arm 2, the order of movies was reversed. After each cycle, mood, fatigue, and other patient-reported outcomes were assessed for comparison with baseline measurements.
RESULTS: The target enrollment of 66 subjects was achieved. Subjects watched humorous content for an average of 96.0 min and non-humorous content for an average of 62.5 min. Negative mood improved after exposure to humorous (p=0.017) and non-humorous content (p=0.001). Patient-reported fear also improved after exposure to both humorous (p=0.038) and non-humorous content (p=0.002). Subjects reported higher use of affiliating and self-effacing humor types.
CONCLUSIONS: Offering patients a choice of digital media during chemotherapy significantly improved negative mood and fear. This was seen with both humorous and non-humorous content. This low-cost and low-risk intervention should be implemented as an attention diversion to improve negative mood and fear for patients receiving chemotherapy. © IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  quality of life (PRO)/palliative care

Mesh:

Year:  2020        PMID: 32122951      PMCID: PMC8034777          DOI: 10.1136/ijgc-2019-001185

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  20 in total

1.  The physiologic effects of humor, mirth, and laughter.

Authors:  W F Fry
Journal:  JAMA       Date:  1992-04-01       Impact factor: 56.272

Review 2.  The impact of humor on patients with cancer.

Authors:  Wanda Christie; Carole Moore
Journal:  Clin J Oncol Nurs       Date:  2005-04       Impact factor: 1.027

3.  The influence of film-induced mood on pain perception.

Authors:  Matisyohu Weisenberg; Tal Raz; Tamar Hener
Journal:  Pain       Date:  1998-06       Impact factor: 6.961

Review 4.  Laughter: the best medicine?

Authors:  Richard T Penson; Rosamund A Partridge; Pandora Rudd; Michael V Seiden; Jill E Nelson; Bruce A Chabner; Thomas J Lynch
Journal:  Oncologist       Date:  2005-09

5.  A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study.

Authors:  Pascal Jean-Pierre; Gary R Morrow; Joseph A Roscoe; Charles Heckler; Supriya Mohile; Michelle Janelsins; Luke Peppone; Amy Hemstad; Benjamin T Esparaz; Judith O Hopkins
Journal:  Cancer       Date:  2010-07-15       Impact factor: 6.860

6.  Depression, anxiety, and quality of life in patients with epithelial ovarian cancer.

Authors:  D Bodurka-Bevers; K Basen-Engquist; C L Carmack; M A Fitzgerald; J K Wolf; C de Moor; D M Gershenson
Journal:  Gynecol Oncol       Date:  2000-09       Impact factor: 5.482

7.  Positive and negative affect after diagnosis of advanced cancer.

Authors:  E Voogt; A van der Heide; A F van Leeuwen; A P Visser; M P H D Cleiren; J Passchier; P J van der Maas
Journal:  Psychooncology       Date:  2005-04       Impact factor: 3.894

8.  Symptom prevalence, characteristics and distress in a cancer population.

Authors:  R K Portenoy; H T Thaler; A B Kornblith; J M Lepore; H Friedlander-Klar; N Coyle; T Smart-Curley; N Kemeny; L Norton; W Hoskins
Journal:  Qual Life Res       Date:  1994-06       Impact factor: 4.147

9.  Cancer patients' expectations of experiencing treatment-related side effects: a University of Rochester Cancer Center--Community Clinical Oncology Program study of 938 patients from community practices.

Authors:  Maarten Hofman; Gary R Morrow; Joseph A Roscoe; Jane T Hickok; Karen M Mustian; Dennis F Moore; James L Wade; Tom R Fitch
Journal:  Cancer       Date:  2004-08-15       Impact factor: 6.860

10.  Humor and Laughter May Influence Health IV. Humor and Immune Function.

Authors:  Mary Payne Bennett; Cecile Lengacher
Journal:  Evid Based Complement Alternat Med       Date:  2007-12-05       Impact factor: 2.629

View more
  1 in total

Review 1.  From Digital Health to Digital Well-being: Systematic Scoping Review.

Authors:  Merlijn Smits; Chan Mi Kim; Harry van Goor; Geke D S Ludden
Journal:  J Med Internet Res       Date:  2022-04-04       Impact factor: 7.076

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.